To test this hypothesis, we have assessed the capacity of various NK cell subsets, defined principally by their expression of CD56 and CD57, to contribute to a recall response to the components of diphtheria–tetanus–pertussis (DTP) vaccine. This evidence concerns the gene NCAM1 and pertussis.